ST. JUDE CHILDREN'S RESEARCH HOSPITAL and Novant Health formed the seventh St. Jude affiliate, to be named the St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital in Charlotte, N.C., formerly known as Novant Health Blume Pediatric Hematology & Oncology.
DANA-FARBER CANCER INSTITUTE, the Harvard T.H. Chan School of Public Health and the Irish Cancer Society formed the Boston-Ireland Prostate Cancer Collaboration, which will conduct and facilitate exchanges of researchers and knowledge between Boston and Ireland.
THE INDIANA UNIVERSITY Melvin and Bren Simon Cancer Center raised more than $720,000 for cancer research at its CHUCKSTRONG Tailgate Gala, the most in its three-year history.
THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY Conquer Cancer Foundation announced the recipients of the 2015 Merit Awards, Oncology Travel Trainee Awards, Medical Student Rotation Awards and Resident Travel Awards.
THE CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS awarded two grants through its academic research program. The grants, totaling $6,000,000, support the recruitment of two top cancer scientists to academic institutions in Texas.
MARGARET KRIPKE is leaving her position as chief scientific officer at the Cancer Prevention and Research Institute of Texas.
SCRIPPS CLINIC MEDICAL GROUP expanded its radiation oncology services to include CyberKnife of Southern California at Vista, Oncology Therapies of Vista and Pacific Radiation Oncology in Encinitas.
JOSEPH GULFO was named executive director of the Rothman Institute of Innovation and Entrepreneurship at Fairleigh Dickinson University.
PURDUE UNIVERSITY Center for Cancer Research was renewed as an NCI-designated basic science cancer center, and was awarded $8 million in funding over the next five years. In its review, the institute rated the center as “outstanding.”
ROCHE acquired CAPP Medical, a genomics research company founded by members of Stanford University, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA in blood. CAPP Medical’s novel technology is designed to isolate and quantify small amounts of ctDNA through a blood draw, which can be […]
